世界のヒアルロン酸製品市場2021年ｰ2028年：製品別（単回注入サイクル、3回注入サイクル、5回注入サイクル）、用途別

• 英文タイトル：Hyaluronic Acid Products Market (Product: Single-injection Cycle, Three-injection Cycle, and Five-injection Cycle; and Application: Osteoarthritis, Ophthalmic Surgery, Dermal Fillers, and Vesicoureteral Reflux [VUR]) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

• レポートコード：MRC2204A106 • 出版社/出版日：Transparency Market Research / 2022年2月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥857,660 (USD5,795)	▷ お問い合わせ
Multi User	￥1,301,660 (USD8,795)	▷ お問い合わせ
Corporate License	￥1,745,660 (USD11,795)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

Transparency Market Research社の本調査レポートは、世界のヒアルロン酸製品市場について調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品別（単回注入サイクル、3回注入サイクル、5回注入サイクル）分析、用途別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを掲載しています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界のヒアルロン酸製品市場規模：製品別（単回注入サイクル、3回注入サイクル、5回注入サイクル） ・世界のヒアルロン酸製品市場規模：用途別 ・世界のヒアルロン酸製品市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況

Hyaluronic Acid Products Market – Scope of Report
TMR’s report on the global hyaluronic acid products market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global hyaluronic acid products market for the period 2018–2028, considering 2020 as the base year and 2021 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global hyaluronic acid products market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global hyaluronic acid products market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global hyaluronic acid products market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global hyaluronic acid products market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global hyaluronic acid products market.

The report delves into the competition landscape of the global hyaluronic acid products market. Key players operating in the global hyaluronic acid products market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global hyaluronic acid products market that have been profiled in this report.

Key Questions Answered in Global Hyaluronic Acid Products Market Report
What is the scope of growth of product companies in the global hyaluronic acid products market?
What will be the Y-o-Y growth of the global hyaluronic acid products market between 2017 and 2028?
What is the influence of changing trends in application on the global hyaluronic acid products market?
Will North America continue to be the most profitable market for hyaluronic acid products product providers?
Which factors are anticipated to hamper the growth of the global hyaluronic acid products market during the forecast period?
Which are the leading companies in the global hyaluronic acid products market?
Research Methodology
TMR has utilized a unique research methodology to conduct comprehensive research on the growth of the global hyaluronic acid products market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global hyaluronic acid products market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the hyaluronic acid products market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the hyaluronic acid products market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global hyaluronic acid products market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global hyaluronic acid products market more reliably and accurately.

レポート目次

---

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hyaluronic Acid Products Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Hyaluronic Acid Products Market Analysis and Forecast, 2018–2028
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. Regulatory Scenario by Region/globally
5.3. Product/ Brand Analysis
5.4. Technological Advancements
5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
6. Global Hyaluronic Acid Products Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2018–2028
6.3.1. Single-injection Cycle
6.3.2. Three-injection Cycle
6.3.3. Five-injection Cycle
6.4. Market Attractiveness, by Product
7. Global Hyaluronic Acid Products Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2018–2028
7.3.1. Osteoarthritis
7.3.2. Ophthalmic Surgery
7.3.3. Dermal Fillers
7.3.4. Vesicoureteral Reflux (VUR)
7.4. Market Attractiveness, by Application
8. Global Hyaluronic Acid Products Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Country/Region
9. North America Hyaluronic Acid Products Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2018–2028
9.2.1. Single-injection Cycle
9.2.2. Three-injection Cycle
9.2.3. Five-injection Cycle
9.3. Market Value Forecast, by Application, 2018–2028
9.3.1. Osteoarthritis
9.3.2. Ophthalmic Surgery
9.3.3. Dermal Fillers
9.3.4. Vesicoureteral Reflux (VUR)
9.4. Market Value Forecast, by Country, 2018–2028
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By Application
9.5.3. By Country
10. Europe Hyaluronic Acid Products Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2018–2028
10.2.1. Single-injection Cycle
10.2.2. Three-injection Cycle
10.2.3. Five-injection Cycle
10.3. Market Value Forecast, by Application, 2018–2028
10.3.1. Osteoarthritis
10.3.2. Ophthalmic Surgery
10.3.3. Dermal Fillers
10.3.4. Vesicoureteral Reflux (VUR)
10.4. Market Value Forecast, by Country & Sub-region, 2018–2028
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By Application
10.5.3. By Country & Sub-region
11. Asia Pacific Hyaluronic Acid Products Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2018–2028
11.2.1. Single-injection Cycle
11.2.2. Three-injection Cycle
11.2.3. Five-injection Cycle
11.3. Market Value Forecast, by Application, 2018–2028
11.3.1. Osteoarthritis
11.3.2. Ophthalmic Surgery
11.3.3. Dermal Fillers
11.3.4. Vesicoureteral Reflux (VUR)
11.4. Market Value Forecast, by Country & Sub-region, 2018–2028
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By Application
11.5.3. By Country & Sub-region
12. Latin America Hyaluronic Acid Products Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2018–2028
12.2.1. Single-injection Cycle
12.2.2. Three-injection Cycle
12.2.3. Five-injection Cycle
12.3. Market Value Forecast, by Application, 2018–2028
12.3.1. Osteoarthritis
12.3.2. Ophthalmic Surgery
12.3.3. Dermal Fillers
12.3.4. Vesicoureteral Reflux (VUR)
12.4. Market Value Forecast, by Country & Sub-region, 2018–2028
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By Application
12.5.3. By Country & Sub-region
13. Middle East & Africa Hyaluronic Acid Products Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2018–2028
13.2.1. Single-injection Cycle
13.2.2. Three-injection Cycle
13.2.3. Five-injection Cycle
13.3. Market Value Forecast, by Application, 2018–2028
13.3.1. Osteoarthritis
13.3.2. Ophthalmic Surgery
13.3.3. Dermal Fillers
13.3.4. Vesicoureteral Reflux (VUR)
13.4. Market Value Forecast, by Country & Sub-region, 2018–2028
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By Application
13.5.3. By Country & Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis By Company (2020)
14.3. Company Profiles
14.3.1. Alcon, Inc.
14.3.1.1. Company Details
14.3.1.2. Business Overview
14.3.1.3. Financial Overview
14.3.1.4. Strategic Overview
14.3.1.5. SWOT Analysis
14.3.2. Anika Therapeutics, Inc.
14.3.2.1. Company Details
14.3.2.2. Business Overview
14.3.2.3. Financial Overview
14.3.2.4. Strategic Overview
14.3.2.5. SWOT Analysis
14.3.3. Allergan, Inc.
14.3.3.1. Company Details
14.3.3.2. Business Overview
14.3.3.3. Financial Overview
14.3.3.4. Strategic Overview
14.3.3.5. SWOT Analysis
14.3.4. F. Hoffmann-La Roche Ltd.
14.3.4.1. Company Details
14.3.4.2. Business Overview
14.3.4.3. Financial Overview
14.3.4.4. Strategic Overview
14.3.4.5. SWOT Analysis
14.3.5. Fidia Farmaceutici SpA
14.3.5.1. Company Details
14.3.5.2. Business Overview
14.3.5.3. Financial Overview
14.3.5.4. Strategic Overview
14.3.5.5. SWOT Analysis
14.3.6. Ferring Pharmaceuticals, Inc.
14.3.6.1. Company Details
14.3.6.2. Business Overview
14.3.6.3. Financial Overview
14.3.6.4. Strategic Overview
14.3.6.5. SWOT Analysis
14.3.7. GALDERMA S.A.
14.3.7.1. Company Details
14.3.7.2. Business Overview
14.3.7.3. Financial Overview
14.3.7.4. Strategic Overview
14.3.7.5. SWOT Analysis
14.3.8. LifeCore Biomedical LLC
14.3.8.1. Company Details
14.3.8.2. Business Overview
14.3.8.3. Financial Overview
14.3.8.4. Strategic Overview
14.3.8.5. SWOT Analysis
14.3.9. Hyaltech Ltd.
14.3.9.1. Company Details
14.3.9.2. Business Overview
14.3.9.3. Financial Overview
14.3.9.4. Strategic Overview
14.3.9.5. SWOT Analysis
14.3.10. Meiji Seika Pharma Co., Ltd.
14.3.10.1. Company Details
14.3.10.2. Business Overview
14.3.10.3. Financial Overview
14.3.10.4. Strategic Overview
14.3.10.5. SWOT Analysis
14.3.11. Sanofi
14.3.11.1. Company Details
14.3.11.2. Business Overview
14.3.11.3. Financial Overview
14.3.11.4. Strategic Overview
14.3.11.5. SWOT Analysis
14.3.12. Merz Aesthetics, Inc.
14.3.12.1. Company Details
14.3.12.2. Business Overview
14.3.12.3. Financial Overview
14.3.12.4. Strategic Overview
14.3.12.5. SWOT Analysis
14.3.13. Salix Pharmaceuticals, Inc.
14.3.13.1. Company Details
14.3.13.2. Business Overview
14.3.13.3. Financial Overview
14.3.13.4. Strategic Overview
14.3.13.5. SWOT Analysis
14.3.14. Shanghai Jingfeng Pharmaceutical Co., Ltd.
14.3.14.1. Company Details
14.3.14.2. Business Overview
14.3.14.3. Financial Overview
14.3.14.4. Strategic Overview
14.3.14.5. SWOT Analysis
14.3.15. Seikagaku Corp.
14.3.15.1. Company Details
14.3.15.2. Business Overview
14.3.15.3. Financial Overview
14.3.15.4. Strategic Overview
14.3.15.5. SWOT Analysis
14.3.16. Smith & Nephew plc.
14.3.16.1. Company Details
14.3.16.2. Business Overview
14.3.16.3. Financial Overview
14.3.16.4. Strategic Overview
14.3.16.5. SWOT Analysis
14.3.17. Zimmer Holdings, Inc.
14.3.17.1. Company Details
14.3.17.2. Business Overview
14.3.17.3. Financial Overview
14.3.17.4. Strategic Overview
14.3.17.5. SWOT Analysis
14.3.18. TRB Chemedica Int. SA
14.3.18.1. Company Details
14.3.18.2. Business Overview
14.3.18.3. Financial Overview
14.3.18.4. Strategic Overview
14.3.18.5. SWOT Analysis
14.3.19. Other Prominent Players
14.3.19.1. Company Details
14.3.19.2. Business Overview
14.3.19.3. Financial Overview
14.3.19.4. Strategic Overview
14.3.19.5. SWOT Analysis

List of Tables

Table 1: Market Snapshot: Global Hyaluronic Acid Products Market (2020 & 2028)

Table 2: Global Hyaluronic Acid Products Market Revenue, by Products, 2017 –2028 (USD Million)

Table 3: Global Hyaluronic Acid Products Market Revenue, by Applications, 2017 –2028 (USD Million)

Table 4: Global Hyaluronic Acid Products Market Revenue, by Geography, 2017 –2028 (USD Million)

---